Today: 20 May 2026
Trex (TREX) stock jumps nearly 9% after Wolfe upgrade as rate bets stay in focus
8 January 2026
1 min read

Trex (TREX) stock jumps nearly 9% after Wolfe upgrade as rate bets stay in focus

New York, January 8, 2026, 13:01 (EST) — Regular session

Shares of Trex Company, Inc (TREX) rose 8.6% to $39.65 by 1:01 p.m. EST on Thursday. The stock opened at $36.10 and hit a session high of $39.66 after Wolfe Research upgraded it to Outperform.

The move matters because Trex has been trying to claw back confidence after a steep 2025 slide, while investors debate how durable demand is for outdoor-living projects. Wolfe set a $47 price target and said the stock’s 2025 drop left it trading at about 12.3 times its 2026 EV/EBITDA — a debt-adjusted valuation measure — far below its long-term average, while pointing to investor worries over competition after James Hardie’s acquisition of AZEK.

BMO Capital analyst Ketan Mamtora reiterated an Outperform rating and a $54 target on Thursday, calling Trex a “high quality name on sale” and saying the stock reaction was “over done,” StreetInsider reported. Trex’s shares had been hit after the company blamed weak market conditions and rate-driven pressure on consumer spending for softer home-improvement demand. Investopedia

Wolfe also argued that consensus 2026 gross margin forecasts look “conservative” and that the discounted valuation “creates a margin of safety,” according to The Fly. Gross margin is the share of sales left after the cost of making a product. TipRanks

Rates are still the big macro lever for housing-linked names, and the tone shifted again on Thursday after Fed Governor Stephen Miran said he would back 150 basis points of cuts this year. Investors will parse the official U.S. jobs report for December on Friday, with the Bureau of Labor Statistics calendar also showing December CPI due on Jan. 13; the Fed’s next policy meeting is scheduled for Jan. 27-28.

But the rally comes with a clear downside case: if demand stays soft, higher selling and administrative costs and gross-margin pressure could weigh on 2026 results. BMO flagged those near-term headwinds even as it said Trex remains the largest North American composite decking producer with roughly 45% market share.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Lockheed Martin stock jumps on Trump’s $1.5 trillion defense-budget call after payout-ban scare
Previous Story

Lockheed Martin stock jumps on Trump’s $1.5 trillion defense-budget call after payout-ban scare

Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking
Next Story

Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking

Go toTop